Connection

JORGE CASTILLO to Protein-Tyrosine Kinases

This is a "connection" page, showing publications JORGE CASTILLO has written about Protein-Tyrosine Kinases.
Connection Strength

1.290
  1. Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative Disorders. Cancer J. 2016 Jan-Feb; 22(1):34-9.
    View in: PubMed
    Score: 0.466
  2. PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies. Expert Opin Investig Drugs. 2012 Mar; 21(3):355-61.
    View in: PubMed
    Score: 0.355
  3. Localized upper extremity edema secondary to Bruton's tyrosine kinase inhibition. Leuk Lymphoma. 2023 12; 64(12):2047-2050.
    View in: PubMed
    Score: 0.198
  4. Novel approaches to targeting MYD88 in Waldenstr?m macroglobulinemia. Expert Rev Hematol. 2017 08; 10(8):739-744.
    View in: PubMed
    Score: 0.129
  5. Ibrutinib in previously treated Waldenstr?m's macroglobulinemia. N Engl J Med. 2015 Apr 09; 372(15):1430-40.
    View in: PubMed
    Score: 0.111
  6. Future therapeutic options for patients with Waldenstr?m macroglobulinemia. Best Pract Res Clin Haematol. 2016 06; 29(2):206-215.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.